Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Sun Pharma reports Q2FY20 results

Posted On: 2019-11-07 16:45:18

Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) reported financials for the second quarter & first half ending September 30th, 2019.

Highlights of Q2FY20 consolidated financials

- Sales / Income from operations at Rs. 7,949 crores, a growth of 16% over same quarter last year.
- India sales at Rs. 2,515 crores, growth of 35% over Q2 last year.
- US finished dosage sales at US$ 339 million, flat over Q2 last year.
- Emerging Markets sales at US$ 201 million, up by 3% Q2 last year.
- Rest of World sales at US$ 161 million, growth of 49% over Q2 last year.
- R&D investments at Rs. 488 crores (6.1% of sales) compared to Rs. 452 crores (6.6% of sales) for Q2FY19.
- EBITDA at Rs. 1,616 crores up by 12% over Q2 last year, with resulting EBITDA margin of 20.3%.
- Net profit for quarter at Rs. 1,064 crores, with resulting net profit margin at 13.4%. Adjusted for the exceptional item of Rs. 1,214 crores for Q2 last year, net profit growth was 12.6%.

Highlights of H1FY20 consolidated financials

- Sales / Income from operations at Rs. 16,208 crores, growth of 16% over same period last year.
- India sales at Rs. 4,828 crores, up by 20% over H1 last year.
- US finished dosage sales at US$ 763 million up by 6% over H1 last year.
- Emerging Markets sales at US$ 394 million up by 1% over H1 last year.
- Rest of World sales at US$ 328 million, growth of 52% over H1 last year.
- EBITDA at Rs. 3,496 crores up by 18% over H1 last year, with resulting EBITDA margin of 21.6%.
- Net profit for H1FY20 at Rs. 2,452 crores, with resulting net profit margin at 15.1%. Adjusted for the exceptional item of Rs. 1,214 crores for H1 last year, net profit growth was 22.5%.

These results were taken on record by the Board of Directors at a meeting held in Mumbai today.

Dilip Shanghvi, Managing Director of the Company said, "Our Q2 and H1 performance demonstrates sustained growth momentum and is in-line with our full-year guidance. We continue to focus on cost savings and efficiency improvement to align our generic business with the changing industry dynamics. Simultaneously, we continue to progress on building our global specialty business. In the US, we recently launched Cequa while Ilumya continues to gain traction. The recently released long-term follow-up clinical data for Ilumya demonstrates sustained response for patients over four-year period with very good safety profile. We are excited about the long term prospects of Ilumya."

Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE at Rs.440.45 as compared to the previous close of Rs. 427.55. The total number of shares traded during the day was 895727 in over 11204 trades.

The stock hit an intraday high of Rs. 444 and intraday low of 423.45. The net turnover during the day was Rs. 389945023.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

CarDekho delivers 92% growth in H1 2019-20

Bajaj Finserv offers lucrative deals on Vivo smartphones

South Indian Bank Ltd revises MCLR from Nov 20, 2019

Tata Chemicals tops 6th edition of ET Edge - Futurescape Responsible Business Rankings 2019 unveiled at Economic Times - SDG Impact Summit

RBI imposes penalty of Rs. 2.50 crores on Bank of Baroda

Alkyl Amines Chemicals Limited has sold its stake in Diamines and Chemicals Ltd

Appirio, MuleSoft Partner to Provide Digital Transformation Solutions

TCS and Govt of Karnataka Rural IT Quiz: Government Excellence School, Dewas, Madhya Pradesh wins National Finals

Infosys Foundation India International Challenge 2019 to host 250 players from 13 countries

Chembond Chemicals Ltd to list in NSE on Nov 20, 2019

Hexaware Developers Win Big at Automation Anywhere's Virtual Bot Games

Lupin launches generic KCl for Oral Solution USP, 20 mEq

Virgin Atlantic Expands Technology Partnership with TCS to Further Enhance Customer Experience

Intellect SEEC powers KSKJ Life with the implementation of AI-powered, cloud-native Fraternal Suite

Birlasoft recognized with 'Companies with Great Managers™' Award

Bharti Airtel announces increase in price from December 2019

Thomas Cook India introduces India's First 'Easy Payment Plan' for Holidays

Maruti Suzuki S-PRESSO debuts as one of India's top 10 bestselling cars within a month of its launch

Dilip Buildcon Ltd declared L1 bidder by Northern Coalfields Ltd

V2 Retail Ltd opens new retail store at Angul Town

Accelya announces acquisition by Vista Equity Partners

Panacea Biotec announces key managerial appointments

Vodafone Idea to increase tariffs effective 1 December 2019

Newgen Positioned as a Challenger in Magic Quadrant for Content Services Platforms by Gartner

YES Bank acquires 20.61% stake in Tulip Star Hotels Ltd

Kiran Mazumdar-Shaw Conferred with Lifetime Achievement Award by Indian Council of Medical Research

Prestige Estates Subsidiary has acquired equity stake in DB (BKC) Realtors Private Limited

Allied Digital Services Limited bags Smart City Project in Aurangabad, Maharashtra

Vishal Fabrics Reported an all-round performance for Q2FY20

TCS Launches Microsoft Business Unit to Help Enterprises Accelerate their Business 4.0™ Transformation Journeys

Tata Communications provides Visteon with a fully managed software-defined wide-area network

Super Crop Safe Limited announces Financial Results for Q2FY20

Pidilite Industries Ltd appoints Mr. Pradip Menon as CFO

Accelya Solutions India Ltd's holding company to be sold

Brickwork downgrades CRNCPS rating of Zee Entertainment Enterprises Ltd

Order of the Rising Sun, Gold and Silver Star by Japanese Prime Minister to Dr Jyotsna Suri, Director

Intellect collaborates with Cambridge Judge Business School for a prestigious Executive Leadership Programme on Digital Transformation

Zydus announces second Phase 3 trial of Desidustat

BHEL commissions 14 Pumping Units of Kaleshwaram Lift Irrigation Scheme in Telangana in a record period of six months

Indian Metals and Ferro Alloys Ltd gets approval for expansion proposal

ICICI Lombard and Fino Payments Bank aim deeper insurance penetration with innovative and affordable insurance products

Mindtree Appraised at CMMI V2.0 Level 5 for Capabilities in Product Development and Services

HCC reports Topline of Rs.988 cr in Q2

The Waterbase Limited announces Q2 FY20 Results

Balkrishna Industries Ltd board declares 2nd interim dividend of Rs. 2 for 2019-20

The Indian Wood Product Co. Limited to shift production from Kundli Unit to Jammu & Kashmir and Bareilly Unit

Glenmark's consolidated revenue rises 9.05% to Rs. 28,150.4 Mn. in Q2 FY 2019-20

Polyplex Corporation Ltd board approves interim dividend of Rs. 11 for 2019-20

Page Industries Ltd board approves interim dividend of Rs. 52 for 2019-20

Saurashtra Cement Ltd board approves interim dividend of Rs. 0.75 for FY20







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019